FINANCIAL YEAR 2020
18.08.2020 - Half-yearly Report
12.11.2020 - Quarterly Report - Q3
Please see new date for Half-yearly Report.
This information is published pursuant to the requirements set out in the
Continuing obligations.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.com
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, which makes
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com or www.cysview.com